Trials / Recruiting
RecruitingNCT03831126
Stress and Fetal Brain Development
The Impact of Stress on Fetal Brain Development
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (estimated)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The current proposal aims to investigate the impact of acute stress on the fetal autonomic nervous system.
Detailed description
Over the last decades there is growing evidence that increased maternal stress levels lead to an adverse effect on the physiological, metabolic and neuronal development of the fetus during gestation with possible long-lasting effects. Several studies showed that maternal stress also affects fetal endocrine processes during pregnancy and increases the risk for childhood and adult obesity. Thus, the aim of the study is to investigate the effect of acute stress related to the action of the artificial glucocorticoid betamethasone on fetal heart and brain activity. The fetal activity will be measured with biomagnetic sensors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Betamethason Sodium Phosphate | First measurement: 12-36 hours after betamethasone treatment Second measurement: within five days after betamethasone treatment and two weeks Third measurement (neonatal measurement): 1-8 weeks after birh |
Timeline
- Start date
- 2019-02-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2019-02-05
- Last updated
- 2024-05-16
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03831126. Inclusion in this directory is not an endorsement.